Shopping Cart
- Remove All
Your shopping cart is currently empty
Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $119 | In Stock | |
| 5 mg | $287 | In Stock | |
| 10 mg | $456 | In Stock | |
| 25 mg | $749 | In Stock | |
| 50 mg | $1,060 | In Stock | |
| 100 mg | $1,420 | In Stock | |
| 500 mg | $2,850 | In Stock |
| Description | Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer. |
| Synonyms | BEY1107, Avotaciclib |
| Molecular Weight | 281.27 |
| Formula | C13H11N7O |
| Cas No. | 1983983-41-0 |
| Smiles | OC1=C(N=C(C=C1)C2=NC(N)=NC=C2)C3=NC(N)=NC=C3 |
| Relative Density. | 1.487 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (177.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.